Workflow
健帆生物(300529) - 2022 Q3 - 季度财报
300529JAFRON(300529)2022-10-27 16:00

Revenue and Profit - The company's revenue for Q3 2022 was ¥471,416,012.01, a decrease of 20.58% compared to the same period last year[3] - Net profit attributable to shareholders for Q3 2022 was ¥125,294,456.51, down 48.43% year-on-year[3] - The net profit after deducting non-recurring gains and losses was ¥120,418,512.92, a decrease of 47.86% compared to the previous year[3] - The company's basic earnings per share for Q3 2022 was ¥0.17, down 43.33% year-on-year[3] - Total operating revenue for the current period reached ¥2,025,701,872.97, an increase of 13.7% compared to ¥1,781,805,266.01 in the previous period[18] - Operating profit for the current period was ¥1,021,591,465.64, slightly up from ¥1,013,971,252.26 in the previous period, reflecting a growth of 0.1%[19] - Net profit attributable to shareholders of the parent company was ¥873,450,879.06, compared to ¥863,085,578.68 in the previous period, indicating a growth of 1.4%[19] - Basic earnings per share increased to ¥1.10 from ¥1.08 in the previous period, while diluted earnings per share rose to ¥1.08 from ¥1.07[20] Assets and Liabilities - The total assets at the end of Q3 2022 reached ¥5,144,905,239.58, an increase of 6.96% from the end of the previous year[3] - As of September 30, 2022, the total assets amounted to approximately CNY 5.14 billion, an increase from CNY 4.81 billion at the beginning of the year[15] - The total liabilities as of September 30, 2022, were approximately CNY 1.53 billion, compared to CNY 1.43 billion at the beginning of the year, indicating an increase of about 7.7%[16] - The company's equity attributable to shareholders rose to approximately CNY 3.59 billion from CNY 3.36 billion, marking an increase of about 6.9%[17] Cash Flow - The cash flow from operating activities for the year-to-date was ¥525,086,171.92, a decrease of 21.17% compared to the previous year[3] - Cash flow from operating activities generated a net amount of ¥525,086,171.92, down from ¥666,139,337.01 in the previous period, a decrease of 21.2%[21] - Cash inflow from investment activities totaled ¥2,113,400,711.80, compared to ¥2,330,043,064.21 in the previous period, reflecting a decrease of 9.3%[21] - The net cash flow from investing activities was -254,490,340.21 CNY, an improvement from -1,329,117,858.58 CNY in the previous year[22] - Total cash inflow from financing activities was 179,546,337.73 CNY, down from 1,192,629,344.86 CNY year-over-year[22] - The net cash flow from financing activities was -545,642,142.51 CNY, contrasting with a positive flow of 371,088,002.33 CNY in the previous year[22] - The cash and cash equivalents at the end of the period totaled 2,040,617,963.33 CNY, an increase from 1,278,225,616.54 CNY year-over-year[22] - The net decrease in cash and cash equivalents was -273,801,552.29 CNY, slightly better than -291,823,998.55 CNY in the previous year[22] Expenses and Costs - Research and development expenses increased by 68.86% year-on-year, totaling ¥162,284,135.93[8] - Total operating costs for the current period were ¥1,065,873,628.42, up from ¥821,488,233.10, representing a growth of 29.8%[18] - The company reported a tax expense of ¥146,865,226.90, slightly up from ¥146,513,524.66 in the previous period[19] Shareholder Information - The total number of ordinary shareholders reached 49,514, with the largest shareholder holding 43.97% of the shares[11] - The company’s largest shareholder, Dong Fan, holds 355,131,867 shares, representing a significant portion of the total equity[11] Inventory and Prepayments - The company reported a significant increase in inventory, which rose by 59.55% due to preparations for annual sales growth[6] - The inventory increased to approximately CNY 313.59 million from CNY 196.55 million, reflecting a growth of about 59.6%[15] - The company has seen a 101.71% increase in prepayments, primarily due to increased procurement prepayments[6] Other Financial Metrics - The weighted average return on equity was 3.62%, down 3.68% from the previous year[3] - The company received a VAT refund of approximately CNY 10.84 million, a significant increase of 3001.52% compared to the same period last year[9] - Cash paid for purchasing goods and services decreased by 30.76% to CNY 72.69 million, primarily due to a reduction in government subsidies received[9] - Cash paid to employees increased by 60.31% to CNY 478.19 million, attributed to an increase in employee count and average salary[9] - Total cash outflow from operating activities rose by 34.10% to CNY 1.72 billion, driven by increased procurement costs and employee compensation[9] - Cash inflow from financing activities decreased by 84.95% to CNY 179.55 million, mainly due to the absence of convertible bond issuance this year[10] - The company paid dividends amounting to CNY 720 million, reflecting a 35.59% increase compared to the previous year[10] Stock Options - The company has 243,016 stock options available for exercise in 2022, with 226,877 options exercised during the reporting period, leaving 16,138 options unexercised[14] Audit Status - The third quarter report was not audited, which may affect the perception of financial reliability[23]